Double Helix Consulting US

July 20 2009

Double Helix Consulting US, a division of London-based Double Helix Development group, has hired Caryn Zieses as a Senior Consultant. She joins a team focused on strategic pricing, reimbursement and market access across the pharmaceutical, biotechnology and medical device industries. She joins from the Pricing & Reimbursement consulting practice of IMS Health, where she worked on projects in drug pricing, market access, clinical trial design, value messaging, payer attitudes, forecasting and commercial assessments, and in a diverse set of therapy areas including those related to the neurosciences, pulmonology, immunology and ophthalmology. Earlier she spent four years in the Equity Research division of Lehman Brothers. She holds an MBA from the Kellogg School of Management, an MEM from Northwestern University, and a BSE in Chemical Engineering from the University of Pennsylvania. Drew Baker, President of Double Helix Consulting US, says the firm’s capabilities will be complemented by Zieses’ ‘vast experience in planning and implementing product development and launch strategies for the US market’ and her ‘intimate knowledge of managed care market structure, formulary management, contracting strategies, and marketing communications.’ Web site: www.doublehelixdevelopment.com . Printer-friendly version of this article. Email this article to a friend. Register for News emails